Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Open this folder and view contents6. Planning bulletin production: schedules and timing
Open this folder and view contents7. The editorial process
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Close this folder11. Organizational and legal issues
View the document11.1 Introduction
View the document11.2 Why does a drug bulletin need a structure?
Open this folder and view contents11.3 Different kind of structures
View the document11.4 How to deal with legal action
Open this folder and view contents11.5 Copyright
View the document11.6 Further reading
Open this folder and view contents12. Evaluating quality and usefulness
Open this folder and view contents13. Partnership and collaboration
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information
 

11.1 Introduction

As soon as a group of people get together and decide to jointly establish a drug bulletin they will need some kind of organizational structure. Without an organizational structure it is difficult to agree on the mission of the group, make decisions, determine working procedures, manage finances and establish legal and contractual relationships with others. The credibility of a drug bulletin depends on a number of factors, including the quality of the information provided, the independence of the editorial board, good editorial procedures and financial independence. A sound economic and organizational base helps to provide for these.

A new bulletin may find it difficult to form its own organization at first. Many bulletins start with two or three doctors or pharmacists working from an office or their clinical practice. If the bulletin remains a small initiative its editors may feel no immediate need to create an organization. However, some of the principles regarding legal responsibility discussed in this chapter may still be relevant. Many new bulletins benefit from the hospitality of another organization. In some cases that organization becomes the bulletin’s permanent home. For example, many drug bulletins are part of a medical or public health school, a health ministry, a hospital or a drug information centre. Being part of another organization has helped bulletins to become established.

Several bulletins have published notes describing the way they work and their organizational structure. This can be very helpful because it makes it clear to readers where the bulletin is from and how the work of the bulletin is undertaken. For examples see DTB [http://www.dtb.org.uk/dtb/content/index.html]; Geneesmiddelenbulletin [http://www.geneesmiddelenbulletin.nl/]; la revue Prescrire, [http://www.prescrire.org/signature/qui/index.php].

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014